ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2,1,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
5,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
6,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
7,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
7,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
7,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
8,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9,1,Headache,Headaches NEC,Headaches,Nerv,N
9,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
9,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
11,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
12,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
13,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
14,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
14,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
14,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
14,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
15,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
15,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
15,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
15,4,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
16,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
16,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
17,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
17,2,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
18,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
18,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
18,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
18,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
19,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
19,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
19,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
19,4,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
20,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
21,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
22,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
23,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
24,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
24,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
25,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
25,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
25,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
26,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
27,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
28,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
29,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
29,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
30,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
31,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
32,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
32,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
33,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
33,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
33,4,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
33,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
33,6,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
33,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
34,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
34,3,Breath holding,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
34,4,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
34,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
35,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
35,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
35,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
35,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
35,5,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
36,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
37,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
38,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
39,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
40,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
41,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
42,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
43,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
50,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
51,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
52,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
53,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
54,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
54,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
55,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
55,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
56,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
58,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
59,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
60,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
61,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
61,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
61,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
62,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,N
62,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
62,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
63,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
64,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
65,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
65,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
65,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
65,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
66,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
67,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
67,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
69,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
70,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
71,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
71,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
71,3,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
72,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
73,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
73,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
73,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
74,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
74,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
75,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
76,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
77,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
78,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
80,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,1,Headache,Headaches NEC,Headaches,Nerv,N
81,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
81,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
81,4,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
81,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
83,1,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
84,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
85,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
86,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
86,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
86,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
87,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
87,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
87,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
87,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
88,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
89,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
90,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
91,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
92,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
92,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
93,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
93,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
93,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
93,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
94,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
95,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
95,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
95,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
95,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
96,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
96,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
97,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
98,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
99,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
99,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
99,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
99,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
100,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
100,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
101,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
102,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
103,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
104,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
105,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
105,2,Headache,Headaches NEC,Headaches,Nerv,N
105,3,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
106,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
106,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
107,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
107,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
108,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
109,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
109,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
110,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
110,2,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
111,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
112,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
112,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
113,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
114,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
114,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
114,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
114,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
114,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
115,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
115,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
116,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
117,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
118,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
118,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
118,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
119,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
119,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
119,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
120,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
120,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
121,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
121,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
121,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
121,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
122,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
122,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
122,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
123,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
123,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
123,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
124,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
125,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
126,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
127,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
127,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
128,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
129,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
130,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
130,2,Hypervitaminosis,Hypervitaminoses NEC,Vitamin related disorders,Metab,N
130,3,Perinatal brain damage,Neonatal disorders due to birth trauma (excl intracranial haemorrhages),Neonatal and perinatal conditions,Preg,Y
130,4,Streptococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
131,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
132,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
132,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
133,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
134,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
135,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
136,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
137,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
138,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
139,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
141,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
141,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
141,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
142,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
143,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
144,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
145,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
146,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
147,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
147,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
147,3,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
148,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
149,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
149,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
149,3,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
150,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
151,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
152,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
152,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
153,1,Haemoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
153,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
153,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
154,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
155,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
155,2,Vitamin K deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
156,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
157,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
157,2,Poor feeding infant,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
158,1,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
159,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
159,2,Activated partial thromboplastin time abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
159,3,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
159,4,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
159,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
159,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
159,7,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
159,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
160,1,Headache,Headaches NEC,Headaches,Nerv,N
160,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
160,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
161,1,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
161,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
162,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
162,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
162,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
163,1,Headache,Headaches NEC,Headaches,Nerv,N
163,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
163,3,Migraine,Migraine headaches,Headaches,Nerv,N
163,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
164,1,Developmental hip dysplasia,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
164,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
164,3,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
165,1,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
166,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
167,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
168,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
169,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
169,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
169,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
169,4,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
169,5,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
169,6,Vitamin K deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
170,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
170,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
170,3,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
171,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
171,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
171,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
171,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
171,5,Vitamin K deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
172,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
172,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
173,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
173,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
174,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
174,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
174,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
175,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
175,2,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
175,3,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
175,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
175,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
175,6,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
176,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
176,2,Haemorrhagic disease of newborn,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
176,3,Vitamin K deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
177,1,Daydreaming,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
177,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
177,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
177,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
178,1,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
179,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
179,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
179,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
180,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
181,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
182,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
183,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
183,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,Y
184,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
184,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
184,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
184,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
184,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
184,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
184,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
184,8,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
184,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
185,1,International normalised ratio fluctuation,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
186,1,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
186,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
187,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
187,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
188,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
188,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
189,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
189,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
190,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
190,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
190,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
190,4,Vitamin A increased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
191,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
192,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
193,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
193,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
193,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
193,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
193,5,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
194,1,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
194,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
195,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
195,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
196,1,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
196,2,Intrapericardial thrombosis,Pericardial disorders NEC,Pericardial disorders,Card,N
197,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
197,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
198,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
198,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
198,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
198,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
199,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
199,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
199,3,Transverse sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
200,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
200,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
201,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
202,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
202,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
203,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
203,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
204,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
204,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
204,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
204,4,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
204,5,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
204,6,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
204,7,Placental insufficiency,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
204,8,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
204,9,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
204,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
204,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
205,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
205,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
206,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
206,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
206,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
206,4,Refeeding syndrome,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
206,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
207,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
208,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
208,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
208,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
209,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,1,Bile acids increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
210,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
210,3,Cholestasis of pregnancy,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
210,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
210,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,6,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
210,7,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
210,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
211,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
211,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
211,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
212,1,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
212,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
212,3,Poor feeding infant,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
212,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
213,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
213,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
213,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
214,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
214,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
214,3,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
214,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
214,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
214,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
214,7,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
215,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
215,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
216,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
217,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
217,2,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
217,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
218,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
219,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
219,2,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
219,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
220,1,Dairy intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
220,2,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
220,3,Gluten sensitivity,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
220,4,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
220,5,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
220,6,Lactose intolerance,Sugar intolerance (excl glucose intolerance),Food intolerance syndromes,Metab,N
220,7,Milk soy protein intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
220,8,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
221,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
222,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
222,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
222,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
223,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
224,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
224,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
225,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
225,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
226,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
226,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
227,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
227,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
227,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
227,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
227,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
227,6,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
228,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
228,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
228,3,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
228,4,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
228,5,Vitamin K deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
229,1,Anaphylactoid shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
230,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
230,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
230,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
230,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
231,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
231,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
231,3,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
232,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
232,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
232,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
232,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
232,5,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
233,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
233,2,Poor sucking reflex,Abnormal reflexes,Neurological disorders NEC,Nerv,N
234,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
234,2,Headache,Headaches NEC,Headaches,Nerv,N
234,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
234,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
235,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
236,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
237,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
237,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
237,3,Multiple allergies,Allergic conditions NEC,Allergic conditions,Immun,N
238,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
238,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
239,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
240,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
241,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
241,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
241,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
241,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
242,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
243,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
243,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
244,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
244,2,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
245,1,Acne infantile,Acnes,Skin appendage conditions,Skin,N
245,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
245,3,Food intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
245,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
245,5,Initial insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
246,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
246,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
247,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
247,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
248,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
248,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
248,3,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
249,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
250,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
250,2,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
251,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
251,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
252,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
252,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
252,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
252,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
253,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
253,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
253,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
253,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
254,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
254,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
254,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
254,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
254,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
254,6,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
254,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
254,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
255,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
255,2,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
256,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
256,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
256,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
257,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
257,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
257,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
258,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
258,2,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
258,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
258,4,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
259,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
259,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
260,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
260,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
260,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
260,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
260,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
261,1,Headache,Headaches NEC,Headaches,Nerv,N
261,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
261,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
261,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
262,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
262,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
262,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
263,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
263,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
263,3,Headache,Headaches NEC,Headaches,Nerv,N
263,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
263,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
264,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
265,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
265,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
265,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
265,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
265,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
266,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
266,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
267,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
267,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
267,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
267,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
267,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
268,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
268,2,Headache,Headaches NEC,Headaches,Nerv,N
268,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
268,4,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
268,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
268,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
268,7,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
269,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
269,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
269,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
269,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
269,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
269,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
270,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
271,1,Headache,Headaches NEC,Headaches,Nerv,N
271,2,Injection related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
272,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
272,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
273,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
273,2,Vitamin A deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
273,3,Vitamin K deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
274,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
274,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
275,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
275,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
276,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
277,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
278,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
278,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
279,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
279,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
280,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
280,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
281,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
281,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
281,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
281,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
281,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
282,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
282,2,Acne,Acnes,Skin appendage conditions,Skin,N
282,3,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
282,4,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
282,5,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
283,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
283,2,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
284,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
284,2,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
284,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
284,4,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
284,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
284,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
284,7,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
284,8,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
284,9,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
285,1,Eye contusion,Eye injuries NEC,Injuries NEC,Inj&P,N
285,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
286,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
287,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
287,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
287,3,Meconium abnormal,Neonatal gastrointestinal disorders,Neonatal and perinatal conditions,Preg,N
287,4,Necrotising enterocolitis neonatal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
288,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
288,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
289,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
290,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
292,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
293,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
293,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
293,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
293,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
293,5,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
293,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
293,7,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
293,8,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
293,9,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
293,10,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
293,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
293,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
294,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
295,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
295,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
295,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
295,4,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
295,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
295,6,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
295,7,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
295,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
295,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
295,10,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
295,11,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
295,12,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
295,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
296,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
296,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
296,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
296,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
296,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
296,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
297,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
297,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
297,3,Hypervitaminosis,Hypervitaminoses NEC,Vitamin related disorders,Metab,N
297,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
298,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
298,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
298,3,Hypervitaminosis,Hypervitaminoses NEC,Vitamin related disorders,Metab,N
298,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
299,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
299,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
299,3,Hypervitaminosis,Hypervitaminoses NEC,Vitamin related disorders,Metab,N
299,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
300,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
301,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
301,2,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
301,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
302,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
303,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
304,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
304,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
304,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
305,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
305,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
306,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
307,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
308,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
308,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
308,3,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
308,4,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
308,5,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
308,6,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
308,7,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
308,8,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
308,9,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
308,10,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
308,11,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
308,12,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
308,13,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
308,14,Klebsiella test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
308,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
309,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
309,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
310,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
310,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
311,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
312,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
312,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
312,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
313,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
313,2,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
314,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
315,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
315,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
316,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
317,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
317,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
317,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
317,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
317,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
318,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
318,2,Developmental coordination disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
318,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
318,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
318,5,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
318,6,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
318,7,Sensory processing disorder,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
319,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
319,2,Bladder discomfort,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
319,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
319,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
319,5,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
319,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
319,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
319,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
319,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
319,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
320,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
320,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
320,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
320,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
321,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
